Neuromuscular mechanisms that contribute to gross motor performance in survivors of childhood acute lymphoblastic leukemia.
Victoria Marchese, Kelly Rock, Teresa York and 2 others
PMID 33935120WHAT IT FOUND
Childhood leukemia survivors jumped significantly lower than matched peers.
They showed slower shin muscle activation, poorer balance, and slower mobility. Jump height correlated with clinical balance and mobility tests, suggesting these simple measures may track rehabilitation progress in clinics without expensive motion labs.
Key findings
01Leukemia survivors had significantly reduced jump height compared to age-matched controls.
02Survivors demonstrated significantly reduced rate of muscle activation in the tibialis anterior, but not in the soleus or gastrocnemius.
03Jump height correlated strongly with balance scores and moderately with mobility times, linking clinical measures to functional performance.
STILL TO COME
How it was doneWhat they foundWhat it means for PTsWhat it means for OTs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
Very small sample size (6 survivors, 6 controls) limits generalizability. No multiplicity corrections for statistical tests due to exploratory nature. Did not measure specific chemotherapy exposure or peripheral neuropathy directly. Gastrocnemius extensibility was measured with the knee extended, which may not reflect functional length during jumping.
Declared interests
Not reported in the provided text.
The easy way to misread this
Do not conclude that strength deficits cause poor jump performance. The study found no significant differences in hip, knee, or ankle joint torques between survivors and controls, suggesting that rate of muscle activation and balance, rather than maximum strength, were the distinguishing factors.